Clinical Trials Browser

Phase 2 × Hodgkin Disease × Thioguanine × Clear all

NCT00587873 2009-06-12

Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)

Phase 2 Completed

Hodgkin Disease, Recurrence